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Abstract
To determine the routine diagnostic methods used and compare the performance in detection of oocysts of Cryptosporidium species and
cysts of Giardia intestinalis in faecal samples by European specialist parasitology laboratories and European clinical laboratories. Two sets of
seven formalin-preserved faecal samples, one containing cysts of Giardia intestinalis and the other, containing oocysts of Cryptosporidium, were
sent to 18 laboratories. Participants were asked to examine the specimens using their routine protocol for detecting these parasites and
state the method(s) used. Eighteen laboratories answered the questionnaire. For detection of Giardia, 16 of them used sedimentation/
concentration followed by light microscopy. Using this technique the lower limit of detection of Giardia was 17.2 cysts/mL of faeces in the
best performing laboratories. Only three of 16 laboratories used fluorescent-conjugated antibody-based microscopy. For detection of
Cryptosporidium acid-fast staining was used by 14 of the 17 laboratories that examined the samples. With this technique the lower limit of
detection was 976 oocysts/mL of faeces. Fluorescent-conjugated antibody-based microscopy was used by only five of the 17 laboratories.
There was variation in the lower limit of detection of cysts of Giardia and oocysts of Cryptosporidium between laboratories using the same
basic microscopic methods. Fluorescent-conjugated antibody-based microscopy was not superior to light microscopy under the conditions
of this study. There is a need for a larger-scale multi-site comparison of the methods used for the diagnosis of these parasites and the
development of a Europe-wide laboratory protocol based upon its findings.
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Introduction
Giardia intestinalis and Cryptosporidium spp. are parasitic proto-
zoa of cosmopolitan distribution. Transmitted by the ingestion
of cysts or oocysts, respectively, in contaminated food or
water, they are major sources of diarrhoeal disease in humans.
They are reported to account for 23–32% of protozoa-related
drinking water outbreaks worldwide [1] and the impact of
climate change is likely to increase the risk of future
water-borne outbreaks of both these parasites [2].
Various methods are available for the laboratory detection
of protozoan parasites in faecal samples. The characteristic
cysts of G. intestinalis measuring 8–12 lm can be found by
examination of the deposit of a formalin–ether or formalin–
ethyl acetate faecal concentrate preparation [3]. Unlike the
cysts of Giardia, the oocysts of Cryptosporidium, measuring
4–6 µm in diameter, do not concentrate well using standard
concentration techniques but can be identified by microscopy
combined with various staining methods, i.e. modified Ziehl–
Neelsen or phenol–auramine-based fluorescence microscopy
of faecal smears [4]. However, because cyst or oocyst
excretion can be sporadic, these diagnostic stages may be
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missed if only one sample is examined, so three consecutive
specimens are commonly requested to increase the chance of
detection. Specific antigen detection methods are also
deployed to diagnose Giardia and Cryptosporidium infection
and these include direct fluorescent-antibody tests, ELISA and
immunochromatographic cartridge assays. Some kit manufac-
turers have combined the detection of both these parasites
into a single kit or test device. Both parasite species can also be
detected in faecal samples using molecular methods.
The choice of methods to detect these protozoa varies
between different clinical laboratories. Therefore, the Euro-
pean Society of Clinical Microbiology and Infectious Diseases
Study Group on Clinical Parasitology in collaboration with
the UK National External Quality Assurance Service (UK
NEQAS) for Parasitology undertook this study to determine
the routine diagnostic tests deployed and evaluate the
sensitivity of the different techniques used for the detection
of oocysts of Cryptosporidium species and cysts of Giardia in
faecal samples.
Materials and Methods
Twenty-two European laboratories were invited to participate
in the study. All the laboratories approached take part in the
UK NEQAS Faecal Parasitology Scheme.
An initial questionnaire was sent to those laboratories to
ascertain the methods that they used to examine for these
parasites in clinical samples. Eighteen laboratories, three from
the UK, two from each of Germany, Norway and Portugal and
one from each of Austria, Croatia, Greece, Italy, the Neth-
erlands, Romania, Slovenia, Sweden and Switzerland accepted
the invitation to participate in the study, 11 were specialist
parasitology laboratories and seven were clinical microbiology
laboratories but all could be considered to be relatively
experienced in the field.
Two distributions, each consisting of seven faecal samples
preserved in formalin, were sent to those laboratories. Each
sample contained 1 mL of faeces equivalent to 1 g because this
is the recommended size of faecal sample for use in
concentration methods. One distribution contained cysts of
G. intestinalis and the other contained oocysts of C. parvum.
Participants were asked to examine one set of samples for
oocysts of Cryptosporidium and the other set of samples for
cysts of Giardia using their routine protocol in each case. All
samples were coded so that study participants could not know
whether they might be positive.
Giardia intestinalis
The specimen containing cysts of G. intestinalis consisted of a
formalin-fixed faecal sample. To evaluate the number of cysts
present, the sample was blended using a processor to ensure
homogeneous distribution of the cysts throughout the spec-
imen. A 20-µL sample of specimen was placed on a microscope
slide, a coverslip was applied and the total area of a
22 9 22-mm cover slip was examined and the number of
Giardia cysts was counted. Using this figure, the number of
cysts per millilitre was found to be 172 000. Five ten-fold
dilutions were made with parasite-negative faeces and tested in
the Department of Clinical Parasitology before distribution by
microscopy following concentration by the Parasep faecal
concentrator, by MERIFLUOR C/G (Meridian Life Science, Inc.,
Memphis, TN, USA) (an in vitro direct fluorescent-antibody
procedure; Meridian Bioscience, Cincinnati, OH, USA) and
ImmunoCard STAT! (Meridian Life Science, Inc.) (an immu-
nochromatographic assay; Meridian Bioscience). All commer-
cial tests were performed according to the manufacturer’s
instructions. The pre-distribution results are shown in Table 1.
Cryptosporidium parvum
The specimen containing oocysts of C. parvum was purchased









acetate concentration MERIFLUOR ImmunoSTAT!
1 172 000 >1 000 +++ Positive
2 Negative Negative Negative Negative
3 172 6 + Negative
4 17 200 750 +++ Positive (weak)
5 Negative Negative Negative Negative
6 17.2 Negative Negative Negative
7 1 720 175 + Negative
A 62 500 39 +++ Weak positive
B 976 1  Negative
C 15 625 18 +++ Negative
D Negative 0  Negative
E 7812 12 +++ Negative
F 1953 1 + Negative
G 3906 3 + Negative
TABLE 1. Concentration of cysts of
Giardia intestinalis andoocystsofCryp-
tosporidium parvum per millilitre
pre-concentration and the number
of cysts/oocysts per coverslip
post-concentration. The oocysts of
Cryptosporidium parvum were stained
with modified Ziehl–Neelsen
post-concentration Specimens 1–7
Giardia intestinalis; Specimens A–G
Cryptosporidium parvum
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100 million oocysts per millilitre. This was diluted in 10%
formalin to give a concentration of one million oocysts per
millilitre. The resulting suspension was added to an equal
volume of liquid faeces, preserved in 10% formalin, which was
negative for parasites. A number of different dilutions were
made and tested in the Department of Clinical Parasitology
before distribution using microscopy following concentration
by the Parasep faecal concentrator and staining by the
modified Ziehl–Neelsen method [3]; by MERIFLUOR C/G
and ImmunoCard STAT!. All tests were performed according
to the manufacturer’s instructions.
Partly as a result of postal problems beyond the laboratory’s
control, only 12 participants responded to the initial survey. As
a result of this and also because the concentration of
Cryptosporidium oocysts present in the specimens was high
with few reported negatives, making it impossible to determine
the analytical sensitivity, a second distribution containing a
lower concentration of oocysts was sent out. The pre-distri-
bution results are shown in Table 1.
Results
Of the 18 participants who agreed to take part in the study,
16 returned results for Giardia and 17 returned results for
Cryptosporidium. The methods used by participants to detect
cysts of Giardia are shown in Table 2 and methods used for
oocysts of Cryptosporidium are shown in Table 3. The results
obtained by participants for microscopy are shown in
Table 4 for Giardia and Table 5 for Cryptosporidium. As the
specimens were formalin-fixed, only the results from
methods that can be used on such specimens are included.
Hence, data from some immunochromatographic tests and
all PCR tests are not shown for either parasite, because
TABLE 2. Methods used by 16 par-
ticipants for the detection of cysts of




the test Appropriate specimens for testing
Light microscopy methods Sedimentation/
concentration
method
14 Fresh faeces or preserved in 10% formalin
Sucrose Gradient
Concentration




Aqua Glo GLa 2 Water particulates. Excluded from analysis
Meridian Bioscienceb
(MERIFLUOR)
1 Fresh faeces, preserved in 10% formalin or SAF
Immunoassay for antigen TechLab Giardiac 3 Fresh faeces or preserved in 10% formalin
Xpect Giardia (Remel)d 2 Fresh faeces, preserved in 10% formalin or SAF
Triage Biositea 1 Fresh, unfixed faeces. Excluded from analysis
Rida screen Giardia
(Biopharm)e
2 Fresh, unfixed faeces. Excluded from analysis
IVD Research Inc. ELISA 1 Fresh faeces, preserved in 10% formalin or SAF
PCR In-house 1 Fresh, unfixed faeces. Excluded from analysis
SAF, sodium acetate-acetic acid formalin.
aWaterborneTM Inc, Clinical and Environmental Parasitology Products, New Orleans, LA, USA.
bMemphis, TN, USA.
cBlacksburg, VA, USA.
dThermo Fisher Scientific, Lenexa, KS, USA
eAn der neuen Bergstraße 17, Darmstadt, Germany.
TABLE 3. Methods used by 17 par-
ticipants for the detection of oocysts
of Cryptosporidium parvum. Some
used more than one method
Method used Kit
No. using
the test Appropriate specimens for testing
Microscopy plus
staining
Modified Ziehl–Neelsen 14 Fresh faeces, faeces preserved in 10% formalin or
methanol fixed slides
Phenol auramine 2 Fresh faeces, faeces preserved in 10% formalin or
methanol fixed slides
Kinyoun stain 1 Fresh faeces, faeces preserved in 10% formalin or
methanol fixed slides







2 Water particulates. Excluded from analysis
Bios GMBHb 1 Fresh faeces, faeces preserved in 10% formalin or SAF
Meridian Bioscience
(Merifluor)
1 Fresh faeces or faeces preserved in 10% formalin
Antigen detection
test
r-Biopharm 1 Fresh unpreserved faeces. Excluded from analysis
Triage Microparasite
Panel Biosite
1 Fresh unpreserved faeces. Excluded from analysis
PCR In-house 1 Fresh unpreserved faeces. Excluded from analysis
EasyMagb 1 Fresh unpreserved faeces. Excluded from analysis
SAF, sodium acetate-acetic acid formalin.
aClinical and Environmental Parasitology Products, New Orleans, LA, USA.
bbioMerieux, INSTITUT ME´RIEUX, Lyon, France.
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fresh unfixed faecal samples are preferred for those kits and
for PCR.
Detection of Giardia cysts
Eight laboratories used more than one test. Four laboratories
gave overall results for each organism as opposed to
individual results by test; two laboratories used a fluores-
cent-antibody-based antigen detection test alone; one labo-
ratory used an antigen detection test alone; one laboratory
stated that their routine was to examine the samples with
PCR in conjunction with other tests. The specialist labora-
tories used a wider range of tests, i.e. concentration
techniques, fluorescent-conjugated antibody-based micros-
copy and immunoassays for antigens, than the non-specialist
laboratories, which used mainly concentration techniques
with one using a fluorescent-conjugated antibody-based
microscopy method.
The lowest limit of cyst detection for the non-reference
laboratories was 17.2 cysts/mL and was achieved by only 2/16
(12.5%) laboratories using concentration followed by micros-
copy compared with 172 cysts/mL achieved by 2/16 (12.5%)
reference laboratories using this method. (Table 4) Compar-
ison of this method with antigen detection tests (used by
reference laboratories only) and fluorescence-based micros-
copy (used by both reference and non-reference laboratories)
showed that the fluorescent-antibody-based antigen detection
tests performed almost as well, detecting 172 cysts/mL.
Performance was similar in reference versus non-reference
laboratories at high cyst numbers but there was a trend to
better performance by non-reference laboratories in detecting
lower cyst numbers (Table 4).
Detection of Cryptosporidium oocysts
Nine laboratories reported the use of more than one test; six
laboratories used modified Ziehl–Neelsen alone; one used a
fluorescence-based antigen detection test alone; two labora-
tories used PCR in conjunction with other tests. The specialist
parasitology laboratories used a wider range of tests, i.e.
modified Ziehl–Neelsen, phenol–auramine and Kinyoun stains
followed by microscopy, fluorescent-conjugated anti-
body-based microscopy and antigen detection tests, than the
non-specialist laboratories, with the latter using mainly mod-
ified Ziehl–Neelsen stain followed by microscopy with one
using a fluorescent-conjugated antibody-based microscopy.
Modified Ziehl–Neelsen staining followed by microscopy had
the lowest limit of oocyst detection (976 oocysts/mL) but it
was only reached in one of 15 laboratories using that method
(Table 5). Using modified Ziehl–Neelsen staining, although the
specialist laboratories were able to detect a lower number of
oocysts of Cryptosporidium than the non-specialist laboratories
(976 oocysts/mL versus 3906 oocysts/mL, respectively), this
was only achieved by one laboratory at each of 1953 and
976 oocysts/mL. However, overall the non-reference labora-
tories had higher detection rates than the reference labora-
tories.
The fluorescent-antibody-based microscopy tests did not
perform better than modified Ziehl–Neelsen staining or
auramine-based fluorescence (Table 5). It was not possible
to compare results with PCR because this test requires
unfixed faecal samples.
Discussion
The aim of this study was to establish the methods used by a
sample of European diagnostic laboratories; determine which
method detected the lowest concentration of parasites (i.e.




No. of participants achieving positive test results
Concentration followed by microscopy n = 15
Reference (n = 8)
Non-reference
(n = 7) Total
0 0 0 0
0 0 1 False positive
(+2 equivocal)
1 False positive
17.2 0 2 (+1 equivocal) (29%) 2 (13%)
172 2 (+1 equivocal) (25%) 4 (57%) 6 (40%)
1720 8 (100%) 6 (86%) 14 (93%)
17 200 8 (100%) 7 (100%) 15 (100%)
172 000 8 (100%) 7 (100%) 15 (100%)
TABLE 5. Method performance in detection of oocysts of Cryptosporidium parvum expressed as number of positive tests
No. of oocysts/mL
Stain followed by microscopy n = 15
Phenol auramine
(ref. labs only) n = 2
Immunofluorescent test
(non-ref. labs only) n = 2Ref. labs n = 7 Non-ref. labs n = 8 Total
0 0 2 False positives 2 Fp 0 0
976 1 (14%) 0 (+1 Equivocal) 1 (7%) 0 0
1953 1 (14%) 0 (+1 Equivocal) 1 (7%) 0 0
3906 5 (71%) 8 (100%) 13 (87%) 2 1
7812 4 (57%) 5 (63%) 9 (60%) 1 0 (+1 Equivocal)
15 625 3 (+1 Equivocal) (43%) 5 (+1 Equivocal) (63%) 8 (53%) 2 1
62 500 4 (57%) 8 (100%) 12 (80%) 2 1
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had the greatest analytical sensitivity) and see if there was a
difference in level of detection achieved by specialist parasi-
tology laboratories and non-specialist clinical laboratories. The
specimens distributed were treated with formalin to ensure
that their morphological integrity was maintained through the
process of specimen preparation, distribution and examination
in the receiving laboratories. This necessary step prevented
the assessment of some antigen detection kits and PCR,
because some antigen detection kits and PCR methods are
adversely affected by the presence of formalin and require
fresh, unfixed faecal samples for optimum performance.
Although it was not possible to supply such material to
participating laboratories in this study, future Parasitology
EQA schemes will need to take account of this. For example, if
there was sufficient demand, a future EQA distribution could
include fresh unfixed samples shipped in PCR extraction
buffer. Microscopy methods require expertise in identifying
parasites and it has been shown that clinical laboratory
personnel have difficulty in some cases in distinguishing
artefacts from the parasite stages present in faecal samples
[5]. Indeed, in this study, one and two laboratories, respec-
tively, reported parasites in the specimens that were negative
for cysts of Giardia and oocysts of Cryptosporidium. As would be
expected for both Giardia and Cryptosporidium, the higher the
concentration of cysts or oocysts in the specimen, the more
likely they were to be detected by microscopic methods.
However, some participants failed to detect cryptosporidial
oocysts in specimens with relatively high concentrations
present (Table 5).
Transposition errors in reporting the results may have
occurred in some cases, because those laboratories that
reported parasites in the negative specimens reported no
parasites in some of the positive samples.
The specialist parasitology laboratories used a wider range
of tests than the clinical laboratories. This is not surprising, as
the specialist laboratories are also likely to be reference
centres.
The method most commonly used for the detection of
Giardia cysts in the laboratories surveyed was a concentration
method followed by microscopy and for Cryptosporidium
oocysts a staining method followed by microscopy. Antigen
detection kits to diagnose these parasites, separately or in
combination, were also deployed although it was notable that
the non-specialist laboratories used mainly concentration
techniques for the detection of Giardia cysts and modified
Ziehl–Neelsen-stained faecal smears for the detection of
Cryptosporidium oocysts.
Specialist laboratories are more likely to be staffed by
personnel with substantial expertise in parasitology. In this
study, specialist laboratories were able to detect oocysts of
Cryptosporidium present at lower numbers than could be
detected by general laboratories, but the reverse was true for
the detection of Giardia cysts. All laboratories in this study
were enrolled in the UK NEQAS Faecal Parasitology scheme
and it is likely that this and other parasitology EQA schemes
deployed in Europe over the last few decades have contributed
to improved standards [5], although there is still more work
required. It must also be noted that the study participants
knew they were looking for Giardia in one set or Cryptospo-
ridium in the other set of specimens, so the results are likely to
be close to their best performance, though it is possible that a
suspected Giardia cyst or Cryptosporidium oocyst might be less
likely to be dismissed as an artefact under the conditions of
this study than in a clinical specimen and this might have
contributed to the false positives encountered.
Unlike many of the reports comparing diagnostic perfor-
mance for these parasites, this was a multi-centre study, but as
the number using each particular diagnostic kit was small,
meaningful statistical analysis comparing the various products
was not feasible. However, it is still possible to see that for
Giardia cyst and Cryptosporidium oocyst detection, fluores-
cent-antibody-based microscopy did not perform better than
light microscopy. In contrast, Garcia et al. [6] reported better
sensitivity using direct immunofluorescence microscopy for
both of these parasites. Tee et al. [7] found the Giardia CEL IF
test (TCS Biosciences Ltd, Botolph Claydon, Buckingham, UK)
to be more sensitive than microscopy of a formalin–ether faecal
concentrate and the Crypto CEL IF test to be more sensitive
than phenol–auramine-based fluorescence microscopy, which
was itself more sensitive than acid-fast staining for the detection
of Cryptosporidium. Kehl et al. [8] reported high sensitivity (96%)
for Cryptosporidium with the MERIFLUOR kit but reported the
same sensitivity for acid-fast staining. Johnston et al. [9] found
the MERIFLUOR direct fluorescent-antibody test to be more
sensitive than the ImmunoCard STAT! and the ProSpecT EZ
microplate assay for Giardia and for detection of Cryptosporidi-
um, the MERIFLUOR direct fluorescent-antibody test was
more sensitive than the ProSpecT microplate assay, the
ImmunoCard STAT! test and acid-fast stained faecal smears,
in all cases testing faecal samples that had been preserved in
10% formalin. Chalmers et al. [10] reported superiority of
fluorescent-antibody-based microscopy for detection of Cryp-
tosporidium, Crypto-Cel IFM achieving 97.4% sensitivity, com-
pared with 92.1% for phenol–auramine-based fluorescence and
75.7% for modified Ziehl–Neelsen staining.
In contrast to other studies or indeed EQA schemes, where
clinical samples are tested on a positive or negative basis, the
present study examined faecal samples for which the number
of cysts or oocysts per gram was known and sought an
end-point, so it was possible to determine the lower limit of
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detection or analytical sensitivity for the tests. For Giardia
pre-distribution, microscopy plus iodine detected cysts in the
sample containing 172 cysts/mL, but failed to do so at
17.2 cysts/mL. Post-distribution, this technique detected cysts
at 17.2/mL, but in only two of 18 laboratories using it, so
although a given technique has an intrinsic lower limit of
detection, it may not be reached operationally by all users.
Table 4 further illustrates this point; in the best performing
laboratories, cyst concentrations as low as 17.2/mL were
detected, yet detection of Giardia cysts was not achieved by all
laboratories until a concentration of 17 200 cysts/mL was
present. For Cryptosporidium the lower limit of detection both
pre-distribution and post-distribution was 976 cysts/mL for
concentration followed by modified Ziehl–Neelsen staining.
For MERIFLUOR the limit was 1953 cysts/mL pre-distribution
and 3906 cysts/mL post-distribution. There is little information
from studies other than this one on test performance versus
cysts or oocysts per gram of faeces, as many of them used
clinical samples with a single established test or a composite
standard of two tests as the reference standard. For example,
in a study of commercial assays for Giardia and Cryptosporidium
detection, Johnston et al. [9] used the MERIFLUOR test to
calculate sensitivity and specificity for the comparator tests.
Although they used cyst numbers to help rank tests, they were
based on the number of cysts or oocysts seen by MERIFLUOR
per drop (approximately 10 lL) of sediment obtained after
formalin–ethyl acetate stool concentration rather than cysts or
oocysts per gram of pre-concentration stool. Quantitative cyst
and oocyst counts are regularly measured to assess drinking
water safety [1] and very sensitive methods have been
developed, such as immunomagnetic bead separation, which
has a limit of detection of two cysts or oocysts per gram of
bovine faeces. Using this method in rural Canada, Lalancette
et al. [1] reported median concentrations of 111 Giardia cysts/
g of calf faeces (maximum 1 939 333 cysts/g) and 333
Cryptosporidium oocysts/g of calf faeces (maximum 44 607 oo-
cysts/g). The best-performing test in the best-performing
laboratory in the present study detected 17.2 Giardia cysts/mL
(gram) of stool so would have detected a good many of the
bovine infections reported by Lalancette et al. [1], but the
Cryptosporidium tests, with the best performer detecting
976 cysts/mL, would have missed many cases of cryptospo-
ridiosis. Unfortunately, although very sensitive, the immuno-
magnetic bead separation technique is too cumbersome for
use on large numbers of clinical samples. Weber et al. [11]
found a lower limit of detection of 5000 Cryptosporidium
oocysts per gram of seeded watery diarrhoeal stool specimens
for both MERIFLUOR and acid-fast staining, though MERIFLU-
OR was positive in more of the samples (9/10 versus 6/10).
Few of the laboratories in the present study used anti-
body-based fluorescence microscopy to detect Giardia or
Cryptosporidium despite many authorities regarding it as the
microscopic method of choice. This may be because it cannot
be automated, or because it does not remove the need for
faecal concentration to detect helminths or indeed protozoa.
PCR is clearly more sensitive than microscopy. For example,
Miller and Sterling described successful detection of a single
Giardia cyst using nested PCR [12]. In the future, multiplex
real-time PCR is likely to become the method of choice for the
detection of Giardia and Cryptosporidium in clinical laboratories.
The clinical and epidemiological need for this is clear. For
example, during 2011 there was an outbreak of cryptosporid-
iosis in a town in northern Sweden. In all, 155 cases were
diagnosed and more than 6000 persons had symptoms. The
drinking water had to be boiled for months. The diagnosis was
not made until a laboratory technician identified Cryptospori-
dium in a routine sample (B. Evengard; personal communica-
tion, 2013). Had multiplex PCR been in use the diagnosis
would have been secured earlier in this large outbreak.
Primary health-care clinicians rarely ask for specific diagnostics
for this parasite, but routine application of multiplex PCR for
faecal pathogens in cases of diarrhoea would address that.
Although only one laboratory in the current survey used
PCR, at least one other laboratory that took part has
introduced PCR for the diagnosis of both these parasites.
EQA schemes will need to adapt to support these assays as
they become widely used.
Conclusions
There is variation in the lower limit of detection of cysts of
Giardia and oocysts of Cryptosporidium between laboratories
using microscopic methods. Surprisingly few laboratories used
antibody-based fluorescence microscopy to detect them.
There is a need for larger-scale comparison of the methods
in use and for more detailed information on the sensitivity
achieved in practice. Development of a Europe-wide labora-
tory protocol should then be planned. As PCR becomes more
widely used in routine laboratories, Parasitology EQA schemes
will need to supply alternative specimens to the formalin-fixed
faecal samples currently distributed.
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